The report, “Site of Service Cost Differences for Medicare Patients Receiving Chemotherapy,” was commissioned by McKesson Specialty Health on behalf of The US Oncology Network. The researchers studied 10 common cancer types that use chemotherapy as a treatment and analyzed costs for Medicare patients from 2006-2009.
They found that the per-patient-per-month allowed costs were $4,361 for those receiving chemotherapy in a physician office and $4,981 for those receiving the treatment in a hospital outpatient setting. Over the course of a year, this difference would grow to approximately $47,500 for physician offices versus roughly $54,000 for hospital outpatient settings.
Related Articles on Oncology Costs:
10 Statistics on Oncologist Compensation
Expert Panel Says Cancer Policy Needs “Radical Shift” to Provide Affordable Care
Study: Chemotherapy, ED Visits Among Top Drivers of Cancer Care Costs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
